Brown, Lisle/Cummings’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.9K | Hold |
1,071
| – | – | 0.02% | 298 |
|
|
2025
Q1 | $78.7K | Buy |
1,071
+85
| +9% | +$6.25K | 0.02% | 293 |
|
|
2024
Q4 | $64.6K | Buy |
986
+78
| +9% | +$5.11K | 0.02% | 302 |
|
|
2024
Q3 | $70.7K | Hold |
908
| – | – | 0.02% | 291 |
|
|
2024
Q2 | $70.8K | Hold |
908
| – | – | 0.02% | 280 |
|
|
2024
Q1 | $61.5K | Hold |
908
| – | – | 0.02% | 275 |
|
|
2023
Q4 | $61.2K | Hold |
908
| – | – | 0.02% | 271 |
|
|
2023
Q3 | $61.5K | Hold |
908
| – | – | 0.03% | 253 |
|
|
2023
Q2 | $65K | Hold |
908
| – | – | 0.03% | 259 |
|
|
2023
Q1 | $63K | Buy |
908
+159
| +21% | +$11K | 0.03% | 257 |
|
|
2022
Q4 | $50.8K | Buy |
749
+31
| +4% | +$2.1K | 0.03% | 264 |
|
|
2022
Q3 | $39.4K | Hold |
718
| – | – | 0.02% | 274 |
|
|
2022
Q2 | $47.4K | Buy |
718
+30
| +4% | +$1.98K | 0.03% | 265 |
|
|
2022
Q1 | $45.6K | Buy |
688
+88
| +15% | +$5.84K | 0.02% | 272 |
|
|
2021
Q4 | $35K | Buy |
+600
| New | +$35K | 0.02% | 301 |
|